Silvia Berardis

455 total citations
12 papers, 345 citations indexed

About

Silvia Berardis is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Hepatology. According to data from OpenAlex, Silvia Berardis has authored 12 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Silvia Berardis's work include Cystic Fibrosis Research Advances (7 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Silvia Berardis is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Silvia Berardis collaborates with scholars based in Belgium, Netherlands and United States. Silvia Berardis's co-authors include Étienne Sokal, Mustapha Najimi, Catherine Lombard, Valérie Rosseels, Adil El Taghdouini, Leo A. van Grunsven, Pau Sancho‐Bru, Juan José Lozano, Patrick Henriet and Sophie Gohy and has published in prestigious journals such as PLoS ONE, Scientific Reports and World Journal of Gastroenterology.

In The Last Decade

Silvia Berardis

10 papers receiving 336 citations

Peers

Silvia Berardis

HEPAT

EPIDE

SURGE

GENET

EDM

Debora Bizzaro Italy

Veerle De Boe Belgium

Valerie Byrnes Ireland

Asmita Pant United States

D. Mukhopadhyay United States

Iris Albers Germany

Marjorie Chelly United States

Yuichiro Kawano Japan

Jacek Rózga United States

Günther Kappert Germany

Debora Bizzaro Italy

Silvia Berardis

166 ×1.1

HEPAT

188 ×1.2

EPIDE

98 ×0.8

SURGE

64 ×0.7

GENET

41 ×0.7

EDM

Citations per year, relative to Silvia Berardis Silvia Berardis (= 1×) peers Debora Bizzaro

Countries citing papers authored by Silvia Berardis

Since Specialization

Citations

This map shows the geographic impact of Silvia Berardis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Berardis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Berardis more than expected).

Fields of papers citing papers by Silvia Berardis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Berardis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Berardis. The network helps show where Silvia Berardis may publish in the future.

Co-authorship network of co-authors of Silvia Berardis

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Berardis. A scholar is included among the top collaborators of Silvia Berardis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Berardis. Silvia Berardis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Qiu, Zhaojun, Bruno Detry, Marylène Lecocq, et al.. (2025). Immunoglobulin A mucosal immunity in people with cystic fibrosis shortly after initiation of highly effective modulator therapy. ERJ Open Research. 11(6). 1369–2024.

2.

Berardis, Silvia, et al.. (2024). One year effect of tezacaftor and ivacaftor on functional exercise capacity and muscle strength in people with cystic fibrosis. Heliyon. 10(5). e26729–e26729. 2 indexed citations

3.

Berardis, Silvia, et al.. (2022). One-minute sit-to-stand test is practical to assess and follow the muscle weakness in cystic fibrosis. Respiratory Research. 23(1). 266–266. 9 indexed citations

4.

Scheers, Isabelle & Silvia Berardis. (2022). Congenital etiologies of exocrine pancreatic insufficiency. Frontiers in Pediatrics. 10. 909925–909925. 4 indexed citations

5.

Berardis, Silvia, et al.. (2021). Vitamin D intoxication in patients with cystic fibrosis: report of a single-center cohort. Scientific Reports. 11(1). 7719–7719. 5 indexed citations

6.

Godefroid, Nathalie, et al.. (2021). Epstein-Barr Virus-associated Pulmonary Tumor: A Pediatric Case and Discussion of the Literature. Journal of Pediatric Hematology/Oncology. 43(7). e957–e961.

7.

Berardis, Silvia, et al.. (2020). SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis. Journal of Cystic Fibrosis. 19(6). 872–874. 14 indexed citations

8.

Berardis, Silvia, et al.. (2018). Comparison between the 1-minute sit-to-stand test and quadriceps strength in patients with cystic fibrosis. OA4991–OA4991. 1 indexed citations

9.

Najimi, Mustapha, Silvia Berardis, Valérie Rosseels, et al.. (2017). Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation. Stem Cell Research & Therapy. 8(1). 131–131. 37 indexed citations

10.

Berardis, Silvia, et al.. (2015). Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects. World Journal of Gastroenterology. 21(3). 742–742. 116 indexed citations

11.

Berardis, Silvia, Catherine Lombard, Adil El Taghdouini, et al.. (2014). Gene Expression Profiling and Secretome Analysis Differentiate Adult-Derived Human Liver Stem/Progenitor Cells and Human Hepatic Stellate Cells. PLoS ONE. 9(1). e86137–e86137. 48 indexed citations

12.

Berardis, Silvia & Étienne Sokal. (2013). Pediatric non-alcoholic fatty liver disease: an increasing public health issue. European Journal of Pediatrics. 173(2). 131–139. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact